Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil Concentration for Intubation in Thyroid Surgery
NCT06162390Completed
- Sponsor
- Kyungpook National University Chilgok Hospital
- Start
- Nov 2023
- Primary completion
- Mar 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of remifentanil, sponsored by Kyungpook National University Chilgok Hospital. Primary endpoint: Optimal effect-site concentration (Ce) of remifentanil. Started Nov 2023; status: completed.
02
Drugs
remifentanil
Beyond the preview
Go deeper on NCT06162390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06162390.